Not everybody with blockages needs surgical intervention. Guidelines recommend against surgery in people with no symptoms and ...

Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until it was removed from the market in 1997 after valvular heart damage and ...

The findings from this single-center retrospective study compare outcomes between 2 groups of patients living with connective ...

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy, ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

Hypertension does not directly cause dyspnoea; however it can lead to long-term effects on the heart and arteries ...

is a type of pulmonary hypertension that causes high blood pressure in the small arteries of the lungs. It is a serious condition that can impair blood flow, causing symptoms like shortness of ...

The following is a summary of “Right atrial reservoir strain as an early predictor of pulmonary hypertension development in ...

Treatments approved for PAH may reduce by half the risk of serious complications or death in patients with repaired ...

The PAH Initiative is hosting a video event in May to provide information about exercise benefits for PAH patients.

Pulmonary hypertension is a common complication of systemic sclerosis and generally portends a very poor prognosis. Response to modern therapy for scleroderma-related pulmonary arterial ...

It’s not clear to me that you need to have this done in absence of symptoms. However, pulmonary hypertension is one condition where I refer my patients to an expert. (Both cardiologists and ...